| Cristina M Speer, LSWAIC | |
|
13037 Ne Bel Red Rd Ste 102, Bellevue, WA 98005-2618 | |
| (425) 502-9945 | |
| Not Available |
| Full Name | Cristina M Speer |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 13037 Ne Bel Red Rd Ste 102, Bellevue, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427778430 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | SC61184182 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Cristina M Speer, LSWAIC 1650 S Topaz Way, Meridian, ID 83642-4474 Ph: (208) 605-7070 | Cristina M Speer, LSWAIC 13037 Ne Bel Red Rd Ste 102, Bellevue, WA 98005-2618 Ph: (425) 502-9945 |
News Archive
arGEN-X, a clinical stage human monoclonal antibody therapeutics company, announces it has attained a key success milestone in its SIMPLE Antibody research and product development collaboration with the Human Genetic Therapies division of Shire Pharmaceuticals. The milestone, which triggered an undisclosed payment from Shire, was the first demonstration of in vivo proof of concept for one of the antibody discovery programs undertaken in the collaboration.
Long-term leaves of absence tied to stress-related diagnoses are often preceded by a long period without any secure and comforting social relations. This is shown in a recently published study in public health science at Karlstad University in Sweden.
Roche announced today the submission of a supplemental new biologics license application (sBLA) with the U.S. Food and Drug Administration to market Pegasys(R) (peginterferon alfa-2a) for the treatment of chronic hepatitis B (CHB).
Challenging risk assessment methods used for decades by toxicologists, a new review of the literature led by environmental health scientist Laura Vandenberg at the University of Massachusetts Amherst suggests that oral gavage, the most widely accepted method of dosing lab animals to test chemical toxicity, does not accurately mimic how humans are exposed to chemicals in everyday life.
Xencor, Inc., a company using Fc engineering for the discovery and development of next-generation antibodies, announced today that the Company received a milestone payment from Pfizer Inc. The amount of the payment was not disclosed. The payment was triggered by the initiation of human clinical trials of a novel monoclonal antibody therapeutic that was optimized using Xencor technologies under a March 2009 technology license agreement.
› Verified 9 days ago
Jarim Lee, Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 13451 Se 36th St, Bellevue, WA 98006 Phone: 425-562-1337 Fax: 425-562-1331 | |
Mr. William R Cooper, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 12951 Bel Red Rd Ste 190, Bellevue, WA 98005 Phone: 206-517-0036 | |
Melissa Galvez, LICSWA Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1400 112th Ave Se Ste 202, Bellevue, WA 98004 Phone: 520-331-1659 | |
Mr. Eldon Byron Vance, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1601 116th Ave Ne, Suite 114, Bellevue, WA 98004 Phone: 425-455-0300 | |
Stephanie S Berg, LICSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 14270 Ne 21st St, Bellevue, WA 98007 Phone: 425-653-5025 Fax: 425-653-5010 | |
Jill Reece, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 16120 Ne 8th St, Bellevue, WA 98008 Phone: 425-747-4004 | |
Alexandra Friedman, LSWAIC Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 12507 Ne Bel Red Rd Ste 100, Bellevue, WA 98005 Phone: 425-371-7825 |